{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:15:24Z","timestamp":1793826924321,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000868"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_019\/0000868"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports","doi-asserted-by":"publisher","award":["LM2018129"],"award-info":[{"award-number":["LM2018129"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports","doi-asserted-by":"publisher","award":["LX22NPO5102"],"award-info":[{"award-number":["LX22NPO5102"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["VR-MH 2014-46602-117891-30"],"award-info":[{"award-number":["VR-MH 2014-46602-117891-30"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006533","name":"Ministerstvo Zem\u011bd\u011blstv\u00ed","doi-asserted-by":"publisher","award":["MZE-RO0423"],"award-info":[{"award-number":["MZE-RO0423"]}],"id":[{"id":"10.13039\/501100006533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008667","name":"National Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007059","name":"Univerzita Palack\u00e9ho v Olomouci","doi-asserted-by":"publisher","award":["IGA_LF_2022_038"],"award-info":[{"award-number":["IGA_LF_2022_038"]}],"id":[{"id":"10.13039\/501100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0060590"],"award-info":[{"award-number":["0060590"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF 125"],"award-info":[{"award-number":["DNRF 125"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.biopha.2023.114801","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T11:10:37Z","timestamp":1682939437000},"page":"114801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cannabis-derived products antagonize platinum drugs by altered cellular transport"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5233-1504","authenticated-orcid":false,"given":"Tereza","family":"Buchtova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-6005","authenticated-orcid":false,"given":"Lucie","family":"Beresova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-0469","authenticated-orcid":false,"given":"Katarina","family":"Chroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7417-0016","authenticated-orcid":false,"given":"Tomas","family":"Pluhacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Beres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0667-7595","authenticated-orcid":false,"given":"Dominika","family":"Kaczorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Tarkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Bartek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-0348","authenticated-orcid":false,"given":"Martin","family":"Mistrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114801_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1595\/003214079X2339098","article-title":"Cisplatin in the treatment of cancer","volume":"23","author":"Wiltshaw","year":"1979","journal-title":"Platin. Met. Rev."},{"key":"10.1016\/j.biopha.2023.114801_bib2","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3390\/molecules27082466","article-title":"Application of approved cisplatin derivatives in combination therapy against different cancer diseases","volume":"27","author":"Tsvetkova","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.114801_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114801_bib4","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.biopha.2023.114801_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00280-016-2976-z","article-title":"Platinum-based drugs: past, present and future","volume":"77","author":"Dilruba","year":"2016","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.biopha.2023.114801_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fphar.2020.00343","article-title":"The drug-resistance mechanisms of five platinum-based antitumor agents","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.114801_bib7","doi-asserted-by":"crossref","first-page":"1691428","DOI":"10.1155\/2018\/1691428","article-title":"Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer","volume":"2018","author":"Pellati","year":"2018","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.biopha.2023.114801_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fphar.2018.00482","article-title":"Cannabidiol as a promising strategy to treat and prevent movement disorders?","volume":"9","author":"Peres","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.114801_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: State of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114801_bib10","first-page":"160","article-title":"Survey Study of breast","volume":"128","author":"Weiss","year":"2022","journal-title":"Cancer patients\u2019 Use Cannabis , , Treat., Cancer"},{"key":"10.1016\/j.biopha.2023.114801_bib11","first-page":"4488","article-title":"Cannabis use among patients at a comprehensive","volume":"123","author":"Pergam","year":"2017","journal-title":"Cancer Cent. a State Leg. Med. Recreat. Use, Cancer"},{"key":"10.1016\/j.biopha.2023.114801_bib12","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1002\/jcp.27725","article-title":"Medical Cannabis: A plurimillennial history of an evergreen","volume":"234","author":"Pisanti","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2023.114801_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2147\/TCRM.S126849","article-title":"Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer","volume":"14","author":"Badowski","year":"2018","journal-title":"Ther. Clin. Risk Manag"},{"key":"10.1016\/j.biopha.2023.114801_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.6004\/jnccn.2012.0048","article-title":"Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting","volume":"10","author":"Todaro","year":"2012","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.biopha.2023.114801_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","article-title":"Cannabidiol as potential anticancer drug","volume":"75","author":"Massi","year":"2013","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2023.114801_bib16","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3390\/ijms24032885","article-title":"Drug\u2013Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics","volume":"24","author":"Buchtova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114801_bib17","article-title":"Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET","author":"Buchtova","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2023.114801_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1021\/acs.jnatprod.9b01200","article-title":"Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes","volume":"83","author":"Sarma","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.114801_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cyto.b.20450","article-title":"Kinetics of H2AX phosphorylation after exposure to cisplatin","volume":"76","author":"Olive","year":"2009","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.biopha.2023.114801_bib20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1357-2725(99)00020-5","article-title":"Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin","volume":"31","author":"Siemer","year":"1999","journal-title":"Int J. Biochem Cell Biol."},{"key":"10.1016\/j.biopha.2023.114801_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jprot.2017.05.005","article-title":"Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells","volume":"162","author":"Ozdian","year":"2017","journal-title":"J. Proteom."},{"key":"10.1016\/j.biopha.2023.114801_bib22","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.3390\/ijms21186928","article-title":"Comparative study of the mode of action of clinically approved platinum-based chemotherapeutics","volume":"21","author":"Schoch","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114801_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fphar.2015.00085","article-title":"Role of transporters in the distribution of platinum-based drugs","volume":"6","author":"Harrach","year":"2015","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.114801_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drup.2010.12.002","article-title":"Drug transporters of platinum-based anticancer agents and their clinical significance","volume":"14","author":"Burger","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2023.114801_bib25","article-title":"SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114801_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/cancers14040894","article-title":"Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines","volume":"14","author":"Sobczak","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2023.114801_bib27","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1038\/s41598-021-94212-6","article-title":"Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations","volume":"11","author":"Anderson","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114801_bib28","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1042\/BCJ20160674","article-title":"Regulation of divalent metal transporter-1 by serine phosphorylation","volume":"473","author":"Seo","year":"2016","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2023.114801_bib29","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1038\/s41598-023-30872-w","article-title":"Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis","volume":"13","author":"Bielawiec","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.114801_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuint.2011.12.002","article-title":"Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells","volume":"61","author":"Juknat","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biopha.2023.114801_bib31","doi-asserted-by":"crossref","first-page":"8471","DOI":"10.1128\/MCB.23.23.8471-8485.2003","article-title":"Activity of Metal-Responsive Transcription Factor 1 by Toxic Heavy Metals and H2O2 In Vitro Is Modulated by Metallothionein","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2023.114801_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1248\/yakushi.20-00247","article-title":"Transcription Factor MTF-1 Involved in the Cellular Response to Zinc","volume":"141","author":"Otsuka","year":"2021","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.biopha.2023.114801_bib33","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.bbamcr.2012.01.005","article-title":"The taste of heavy metals: Gene regulation by MTF-1","volume":"1823","author":"G\u00fcnther","year":"2012","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.biopha.2023.114801_bib34","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2217\/fon-2018-0530","article-title":"Cannabinoids: the lows and the highs of chemotherapy-induced nausea and vomiting","volume":"15","author":"Mortimer","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2023.114801_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12906-019-2803-2","article-title":"Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews","volume":"20","author":"Montero-Oleas","year":"2020","journal-title":"BMC Complement Med Ther."},{"key":"10.1016\/j.biopha.2023.114801_bib36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.biopha.2023.114801_bib37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","article-title":"Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial","volume":"13","author":"Portenoy","year":"2012","journal-title":"J. Pain."},{"key":"10.1016\/j.biopha.2023.114801_bib38","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","article-title":"An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics","volume":"46","author":"Johnson","year":"2013","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.biopha.2023.114801_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2049463717710042","article-title":"Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies","volume":"11","author":"Fallon","year":"2017","journal-title":"Br. J. Pain."},{"key":"10.1016\/j.biopha.2023.114801_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpainsymman.2017.09.001","article-title":"Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain","volume":"55","author":"Lichtman","year":"2018","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.biopha.2023.114801_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255591","article-title":"Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells","volume":"16","author":"Inkol","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114801_bib42","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.3390\/ijms23126752","article-title":"Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines-An Isobolographic Analysis","volume":"23","author":"Marz\u0119da","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114801_bib43","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.3390\/ijms21155409","article-title":"The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer","volume":"21","author":"Marinelli","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114801_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060781","article-title":"Cannabidiol Overcomes Oxaliplatin Resistance by Enhancing NOS3- and SOD2-Induced Autophagy in Human Colorectal Cancer Cells","volume":"11","author":"Jeong","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2023.114801_bib45","unstructured":"J.R. Andersen, The Effect of Medical Cannabidiol on Lean Body Mass in Patients Receiving Oxaliplatin or Paclitaxel Based Chemotherapy, clinicaltrials.gov, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04585841 (accessed January 16, 2023)."},{"key":"10.1016\/j.biopha.2023.114801_bib46","unstructured":"Leaf Vertical Inc, Randomized Double-Blind, Placebo-Controlled Parallel Multi-Center Study to Assess the Efficacy of Cannabidiol (BRCX014) Combined With Standard-Of-Care Treatment in Subjects With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies, clinicaltrials.gov, 2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03607643 (accessed April 18, 2022)."},{"key":"10.1016\/j.biopha.2023.114801_bib47","unstructured":"Zealand University Hospital, A Phase II Trial of Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy in Patients Receiving Oxaliplatin or Paclitaxel Based Chemotherapy, clinicaltrials.gov, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04582591 (accessed January 16, 2023)."},{"key":"10.1016\/j.biopha.2023.114801_bib48","unstructured":"Effect of Hemp-CBD on Patients With CIPN - Tabular View - ClinicalTrials.gov, n.d. https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04398446 (accessed January 18, 2023)."},{"key":"10.1016\/j.biopha.2023.114801_bib49","doi-asserted-by":"crossref","DOI":"10.1177\/1758835921990203","article-title":"Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis","volume":"13","author":"Waissengrin","year":"2021","journal-title":"Ther. Adv. Med Oncol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223005917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:44:00Z","timestamp":1780335840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223005917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":49,"alternative-id":["S0753332223005917"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114801","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis-derived products antagonize platinum drugs by altered cellular transport","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114801"}}